Pandora CDx™

The Pandora CDx developed by POC Medical Systems is a microfluidic platform for rapid, point-of-care screening. It is based on a unique, low cost disposable microfluidic disk. The platform is a very simple and easy-to-use system which seeks to replace laboratory ELISA-based screening technology. The technology provides for a simultaneous molecular test for the presence of 48 serum markers at the point of care and is ideal for screening capabilities for other life-threatening diseases.

Our instrumentation is fully automated from start-to-finish. Once blood is drawn from the finger and introduced into the sample port, microfluidics and centrifugal force replace the work done in the lab by technicians.

Blood Separation

We also separate whole blood into plasma using centrifugal force. However, that process is done on our CD and takes only a few minutes without requiring multiple points of involvement from lab technicians.

Mixing

The plasma is then siphoned automatically into metering chambers where a precise aliquot of plasma is measured; all of the excess is automatically transferred into the waste chamber. The precise amount of sample is then transferred automatically into incubation chambers.

Incubation

Here the pre-loaded reagents and sample mix together to allow for the specific capture of the analyte we measure. The capture analyte is transferred automatically into the sedimentation chamber where unreacted reagents are separated from reacted reagents and form a pellet which is then measured by our optical detection system. The concentration of the single analyte is then measured. Multiple analytes can be measured on the same device.

Detection

The capture analyte is transferred automatically into the sedimentation chamber where unreacted reagents are separated from reacted reagents and form a pellet which is then measured by our optical detection system. The concentration of the single analyte is then measured. Multiple analytes can be measured on the same device.

How the Pandora CDx-MammoAlert™ System works

Just Three Simple Steps

Only three simple steps to screen for breast cancer:
Prick a finger - Load sample into the MammoAlert disk and run test - Obtain test results in ~30 minutes
The MammoAlert is a multiplexed, microfluidics-based, immunoassay test which uses just a drop or two of blood from a finger prick to screen for the critical biomarkers of breast cancer. This is run on the Pandora CDx, a lab-in-a-box with POC Medical System’s proprietary Machine Learning algorithms with test-to-result time in just 30 minutes. By POC’s secure cloud computing technologies, the data can be retrieved by a doctor from any remote location, enabling quick and early decision making.

Pandora CDx™

The Existing Laboratory Process

Blood Separation

Mixing

Incubation

How Detection is Performed in the Lab

How the Pandora CDx™ Miniaturizes the Laboratory Process

Our instrumentation is fully automated from start-to-finish. Once blood is drawn from the finger and introduced into the sample port, microfluidics and centrifugal force replace the work done in the lab by technicians.

Blood Separation

Mixing

Incubation

Detection

How the Pandora CDx-MammoAlert™ System works

Just Three Simple Steps

A Snapshot Of The Product

The Advantages Of Using The Pandora CDx-MammoAlert System